According to Fixygen, JSC “Sarnifarmatsiya” will hold its annual shareholders’ meeting on April 24, 2026, via remote participation. The agenda includes the approval of the company’s annual results, financial statements, and other decisions regarding its current operations.
Sarnifarmatsiya operates in pharmaceutical retail and specialized trade in medicinal products.
The company operates in the Rivne region and is one of the regional pharmaceutical operators. According to publicly available data, major shareholders include Tetiana Orel, Yevheniia Petryshyna, and Roslav Petryshyn, while Oleksii Tats’kyi is listed as a beneficial owner.
